Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 75,414 | 64,387 | 62,404 | 58,228 | 59,580 |
| Operating Income | -75,414 | -64,387 | -62,404 | -58,228 | -59,580 |
| Other Income | 4,780 | 5,437 | 4,056 | 3,863 | 4,198 |
| Pre-tax Income | -70,634 | -58,950 | -58,348 | -54,365 | -55,382 |
| Net Income Continuous | -70,634 | -58,950 | -58,348 | -54,365 | -55,382 |
| Net Income | $-70,634 | $-58,950 | $-58,348 | $-54,365 | $-55,382 |
| EPS Basic Total Ops | -0.52 | -0.43 | -0.49 | -0.16 | -0.64 |
| EPS Basic Continuous Ops | -0.64 | -0.59 | -0.62 | -0.64 | -0.64 |
| EPS Diluted Total Ops | -0.52 | -0.43 | -0.49 | -0.16 | -0.64 |
| EPS Diluted Continuous Ops | -0.64 | -0.59 | -0.62 | -0.64 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.59 | -0.62 | N/A | N/A |
| EBITDA(a) | $-80,994 | $-61,200 | $-63,201 | $-61,932 | $-58,090 |